F. De Baets (Ghent, Belgium), M. Ballmann (Hannover, Germany)
Fatal invasive aspergillosis in a non-neutropenic cystic fibrosis patient post liver transplantation
A. Powell, H. Thomas, S. Langton Hewer, J. Dyer, J. Wong, J. Henderson (Bristol, United Kingdom)
|  |
Isolation of Achromobacter xylosoxidans from the respiratory secretions of patients with cystic fibrosis: frequency in the population and significance to the progression of lung disease
W. Balinska-Miskiewicz, K. De Boeck (Leuven, Belgium; Wroclaw, Poland)
| |
A novel CFTR mutation found in a Chinese cystic fibrosis patient
N. Li, P. Pei, D. F. Bu, B. He, G. F. Wang (Beijing, China)
| |
Functional chloride secretion, CFTR-sequencing and transcript analysis in patients with inconclusive results in sweat test and CFTR-mutation screening
M. Ballmann, N. Derichs, J. Sanz, C. Rokahr, U. Laabs, B. Siebert, B. Tuemmler, S. Gallati (Hannover, Germany; Bern, Switzerland)
| |
The association between polymorphisms of GSTM1 genes and severity clinical picture in CF children
L. Jelenina, N. Efimova, T. Ivaschenko (St. Petersburg, Russian Federation)
| |
Limitations of sweat conductivity determinations with Nanoduct analyzing system for rapid sweat testing in patients with cystic fibrosis
J. Barben, R. A. Ammann, M. C. Desax, M. H. Schoeni (St. Gallen, Bern, Switzerland)
| |
Interleukin-10 genotypes and airways colonization by Aspergillus fumigatus in cystic fibrosis patients
J. Brouard, N. Knauer, H. Corvol, P. Y. Boelle, A. Henrion-Caude, C. Flamant, M. Boule, F. Ratjen, H. Grasemann, A. Clement (Paris, France; Essen, Germany)
| |
The role of MBL in B. cepacia infections in CF patients
S. Norbedo, I. Giuseppin, T. Gerarduzzi, F. Poli (Trieste, Italy)
| |
Tumor necrosis factor-α gene polymorphism and inflammatory process in cystic fibrosis patients
G. V. Shmarina, A. L. Pukhalsky, N. V. Petrova, D. A. Pukhalskaya, N. J. Kashirskaja (Moscow, Russian Federation)
| |
Pro-inflammatory cytokines in cystic fibrosis lungs
T. Bulgakova, E. Surkova, T. Ses, L. Jelenina, E. Boitsova, T. Guembitskaia (St. Petersburg, Russian Federation)
| |
High proteasome activity and absence of NF-kB activation in cystic fibrosis cell culture and CF KO mouse models in response to oxidative stress
E. Boncoeur, O. Tabary, E. Bonvin, A. Clément, A. Henrion-Caude, J. Jacquot (Paris, France)
| |
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
A. L. Pukhalsky, G. V. Shmarina, K. A. Zykov, D. A. Pukhalskaya, N. I. Kapranov (Moscow, Russian Federation)
| |
Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis
S. Jouneau, G. Leveiller, B. Desrues, V. Lagente, C. Martin-Chouly (Rennes, France)
| |
Nasal NO in cystic fibrosis is associated with CFTR genotype, pseudomonas colonization and fatty acids
C. Keen, A. C. Olin, A. Edentoft, E. Gronowitz, B. Strandvik (Gothenburg, Sweden)
| |
Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis
M. Hofer, L. Mueller, E. W. Russi, A. Boehler (Zurich, Switzerland)
| |
Usefulness of specific airway resistance in pre-school children with cystic fibrosis
E. Bucchioni, D. Costantini, M. C. Russo, F. Blasi, A. Brivio, C. Colombo, L. Allegra (Milan, Italy)
| |
Cystic fibrosis severity and bronchial hyperresponsiveness
J. Valverde-Molina, M. Sánchez-Solís, M. D. Pastor, P. Mondéjar, L. Garcia-Marcos (Santiago de la Ribera, Murcia, Spain)
| |
Ability of chest radiograph (CXR) scores and lung function tests to detect abnormalities in infants with cystic fibrosis (CF)
W. Kozlowska, S. Ranganathan, R. Dinwiddie, C. Owens, J. Stocks, A. Bush (London, United Kingdom)
| |
The Greek version of the Cystic Fibrosis Questionnaire (CFQ)
E. Hatziagorou, I. Loukou, S. Doudounakis, S. Saraphidou, A. Quittner, J. Tsanakas (Thessaloniki, Athens, Greece; Florida, United States Of America)
| |